908 Devices founder plans sale of 20,000 shares
Kevin Knopp has filed a Form 144 indicating an intent to sell up to 20,000 shares of MASS common stock through Merrill Lynch on NASDAQ.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kevin Knopp has filed a Form 144 indicating an intent to sell up to 20,000 shares of MASS common stock through Merrill Lynch on NASDAQ. These shares are identified as Founder Shares acquired from the issuer for cash on 02/10/2012. The filing notes that MASS had 37,813,621 common shares outstanding as of 08/17/2026 and that Knopp has sold multiple small common stock blocks in the open market over the past three months.
Key Figures
Key Terms
Form 144 regulatory
Securities To Be Sold regulatory
Securities Sold During The Past 3 Months regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does MASS's Form 144 filed by Kevin Knopp disclose?
What recent MASS (MASS) stock sale activity by Kevin Knopp is listed?
AI-generated analysis. How Rhea-AI works. Not financial advice.